These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39001570)

  • 21. Monoamine oxidase inhibitors: a new generation.
    Robinson DS
    Psychopharmacol Bull; 2002; 36(3):124-38. PubMed ID: 12473970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.
    Culpepper L
    Prim Care Companion CNS Disord; 2013; 15(5):. PubMed ID: 24511450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
    Patkar AA; Pae CU; Masand PS
    CNS Spectr; 2006 May; 11(5):363-75. PubMed ID: 16641841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressants for the treatment of depression in people with cancer.
    Vita G; Compri B; Matcham F; Barbui C; Ostuzzi G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD011006. PubMed ID: 36999619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAO inhibitors in mental disease: their current status.
    Dowson JH
    J Neural Transm Suppl; 1987; 23():121-38. PubMed ID: 3295114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants and benzodiazepines for panic disorder in adults.
    Bighelli I; Trespidi C; Castellazzi M; Cipriani A; Furukawa TA; Girlanda F; Guaiana G; Koesters M; Barbui C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011567. PubMed ID: 27618521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
    Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
    Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for somatoform disorders in adults.
    Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
    Chockalingam R; Gott BM; Conway CR
    Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.